New Analysis Underscores How Big Pharma’s Price Increases Cost The American Health System and Are Disconnected from Any Actual Innovation A new analysis from the Institute of Clinical and Economical Review (ICER) finds that brand name drug makers’ price hikes on just seven drugs cost the U.S. an additional $1.67 billion in 2020. ICER’s most […]
AstraZeneca’s Q3 Earnings Report Shows Pandemic Price Hikes Profitable for Brand Name Drug Maker A late third-quarter earnings report from brand name drug makers AstraZeneca shows once again that the pandemic has proven hugely profitable for Big Pharma. AstraZeneca followed other Big Pharma giants that performed well in the third quarter of the year after […]
New Round of Q3 Earnings Reports Continue to Show Big Pharma Profits Buoyed By Pandemic Price Hikes Another round of third quarter earnings reports from Big Pharma giants Sanofi, AbbVie, Pfizer and Amgen demonstrate that the pharmaceutical industry continues to ride high on big profits. All four brand name drug makers topped Wall Street expectations […]
New Analysis Highlights How Big Pharma Uses Limitless Resources, Fueled by Blockbuster Profits, to Fight Solutions That Would Help Americans Afford Their Medications In case you missed it: A new report showcases just how far Big Pharma has gone this year to put profits over people — by deploying vast resources from the industry’s limitless […]
New Q3 Earnings Reports Underscore How Price Hikes, Anti-Competitive Tactics Boost Branded Drug Company Profits Another batch of third quarter earnings reports from brand name drug makers Novartis, Merck, GlaxoSmithKline and Bristol-Myers Squibb demonstrate yet again that hiking pricing on prescription drugs is bigtime profitable for Big Pharma. All four drug makers beat Wall Street […]
AHIP Study Finds Top Drug Companies’ Sales and Marketing Budgets Swamp R&D Budgets In case you missed it, America’s Health Insurance Plans (AHIP) released a new study Wednesday that found Big Pharma continued to spend more advertising and selling its products than investing in research and development (R&D) even amid unprecedented focus on the development […]
First Round of Q3 Earnings Reports Show Big Pharma Companies Raking in Big Profits After Major Rounds of Pandemic Price Hikes Brand name drug makers Johnson & Johnson and Roche kicked off the first round of earnings reports from Big Pharma for the third quarter of the year this week. Both companies bested Wall Street […]
Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented Momentum to Hold Big Pharma Accountable Prescription drug prices are out-of-control and the momentum for Congress to act is unprecedented. A recent national survey from The Campaign for Sustainable Rx Pricing (CSRxP) found more than one-in-four American voters say they or a family member has […]
New Survey Contributes to Unprecedented Momentum for Congress to Hold Big Pharma Accountable, Tracks Recent Findings Demonstrating Urgency for Action In case you missed it, new polling from AARP Arizona finds that an overwhelming majority of voters in the state support solutions to lower prescription drug prices and want to see their elected officials take […]
Voters Expect Congress to Hold Big Pharma Accountable and Lower Drug Prices Morning Consult Lauren Aronson September 30, 2021 https://morningconsult.com/opinions/voters-expect-congress-to-hold-big-pharma-accountable-and-lower-drug-prices/ Lawmakers have a historic opportunity to lower prescription drug prices for the American people — and the momentum for action has never been greater as Congress considers solutions to address the national crisis of […]